Biotrajectory AI:
The Data Intelligence Engine for
Drug Discovery
Biotrajectory AI meticulously analyzes vast amounts of literature, patents, and clinical data,
providing the clarity and speed
you need to make breakthrough decisions.
By supporting every stage of early discovery,
Biotrajectory AI transforms unstructured
scientific knowledge into
structured, actionable intelligence across the following analytical
modules:
Literature & Patent Analysis
We provide a comprehensive review of
research backgrounds, biological functions, and the
entire R&D history of
related drugs. Our system also collates
and interprets
compound patents,
offering insights for Best-in-Class (BIC)
or First-in-Class (FIC)
development
strategies.
Structure &
Molecular Design
We model target-drug binding,
analyze structure-activity relationships,
and propose new molecular designs.
Our AI evaluates and screens potential
molecules to maximize your chances of
success
in lab validation.
Clinical Analysis
We analyze the success and failure of drugs in clinical trials to help you refine
your development strategy.
